News

dianax has been nominated the # 1 Start-up at BigBooster International Start-Up Acceleration Program in Lyon this week. (www.bigbooster.org ). Out of the 250 startups participating from Europe, Middle East and Africa, dianax ranked among the best 44 back...

The Italian financial journal Il Sole 24 Ore on its Magazine Platinum – Aziende & Protagonisti (Platinum – Companies and Business Leaders, in its English version) has published today a one-page article on Dianax in the issue of March 2018 under the...

According to a new market research report from MarketsandMarkets, the global home healthcare market is expected to reach USD 365 Billion by 2022 growing at a CAGR of 8.8 from 2017 to 2012. Testing, screening, and monitoring devices are expected to dominate...

At the end of a 3-day intensive program combining tutorial on best practices, mentoring and individual coaching, dianax ‘s pitch was recognized by an expert jury among the best in class and is qualified for the next round that will take the top 20 startups...

dianax miniaturized microfluidics-based lab-on-a-chip will bring laboratory testing to the patient’s fingertips including HbA1c and CRP. According to Data Bridge Market Research, the Europe Point-of-Care Testing (POCT) devices market is expected to reach...

Organized across the globe, from Lyon (FR) to Boston (MA, USA), passing through China, Middle East & Africa, BigBooster unique international non-profit acceleration program aims at empowering startups to cross borders, think global and go...

dianax is among the top 10 Alpine region startup companies qualified for the 2017 final of the Tech Tour European Venture Contest (EVC). A total of 105 companies applied to the event, only 40 of them were invited to pitch in front of international...

Dianax is among the top 40 Alpine region companies selected to present at the Forum on 10 October in Lausanne. 104 companies applied and were reviewed by the Expert Jury over the past months. At the Alpine Venture Forum 2016 took part +50 Swiss and...

According to a very recent report from Reports Monitor (ReportsMonitor.com), Point of care (POC) technologies are rapidly becoming parts of the revolution of the healthcare landscape, with evolving high–tech innovations in healthcare, including smartphone...

C-reactive protein (CRP) point of care tests may help reduce unnecessary antibiotic use. Sinus infections are one of the most common reasons patients walk out of the doctor’s office with an antibiotic prescription in hand. The problem is that bacteria...

According to IBM's latest predictions, medical device labs-on-a-chip will serve as health detectives for tracing disease at the nanoscale. In the next five years, new medical device labs-on-a-chip will serve as nanotechnology health detectives – tracing...

Type 2 diabetes has escalated to epidemic and financially catastrophic proportions, and is expected to affect one in three US adults by 2050. We already have more than 29 million diabetics in this country today; 28% remain undiagnosed. With the well-established...

Dental patients with severe periodontitis may have undiagnosed type 2 diabetes, Dutch researchers have discovered in a study that suggests targeted screening of individuals with worse gum disease could be a feasible way of picking up cases of diabetes at...

…. Clara Camaschella, MD, Deputy Director Division of Genetics and Cell Biology, Head of the Unit “Regulation of iron metabolism”, Professor of Internal Medicine, University hospital San Raffaele Milan, Italy; Anders Larsson, MD, PhD, Professor, Section of...

dianax is pleased to announce the first members of its newly formed Clinical Advisory Board ("CAB"). The CAB, comprising key thought leaders in point of need testing and subject matter experts in diabetes and iron metabolism therapy management will provide...

HbA1c may be the most effective method to identify patients with undiagnosed prediabetes and diabetes, and point-of-care testing further enhances that screening ability in primary-care settings, new research suggests. The findings were published...

Eugenio Iannone, Dianax Founder and seminal book author of Labs on Chip: Principles, Design & Technology explains: “Miniaturization is one of the key technology that have changed the human life in the last decades, allowing to pack a huge number of...

One step closer to industrialization … dianax announces successful transfer of its BioMEMS chip technology to Silex Microsystems which will industrialize the present prototype and can produce the chip up to a volume of several million pieces a year. Silex...

dianax has been nominated the # 1 Start-up at BigBooster International Start-Up Acceleration Program in Lyon this week. (www.bigbooster.org ). Out of the 250 startups participating from Europe, Middle East and Africa, dianax ranked among the best 44 back...

The Italian financial journal Il Sole 24 Ore on its Magazine Platinum – Aziende & Protagonisti (Platinum – Companies and Business Leaders, in its English version) has published today a one-page article on Dianax in the issue of March 2018 under the...

According to a new market research report from MarketsandMarkets, the global home healthcare market is expected to reach USD 365 Billion by 2022 growing at a CAGR of 8.8 from 2017 to 2012. Testing, screening, and monitoring devices are expected to dominate...

At the end of a 3-day intensive program combining tutorial on best practices, mentoring and individual coaching, dianax ‘s pitch was recognized by an expert jury among the best in class and is qualified for the next round that will take the top 20 startups...

dianax miniaturized microfluidics-based lab-on-a-chip will bring laboratory testing to the patient’s fingertips including HbA1c and CRP. According to Data Bridge Market Research, the Europe Point-of-Care Testing (POCT) devices market is expected to reach...

Organized across the globe, from Lyon (FR) to Boston (MA, USA), passing through China, Middle East & Africa, BigBooster unique international non-profit acceleration program aims at empowering startups to cross borders, think global and go...

dianax is among the top 10 Alpine region startup companies qualified for the 2017 final of the Tech Tour European Venture Contest (EVC). A total of 105 companies applied to the event, only 40 of them were invited to pitch in front of international...

Dianax is among the top 40 Alpine region companies selected to present at the Forum on 10 October in Lausanne. 104 companies applied and were reviewed by the Expert Jury over the past months. At the Alpine Venture Forum 2016 took part +50 Swiss and...

According to a very recent report from Reports Monitor (ReportsMonitor.com), Point of care (POC) technologies are rapidly becoming parts of the revolution of the healthcare landscape, with evolving high–tech innovations in healthcare, including smartphone...

C-reactive protein (CRP) point of care tests may help reduce unnecessary antibiotic use. Sinus infections are one of the most common reasons patients walk out of the doctor’s office with an antibiotic prescription in hand. The problem is that bacteria...

According to IBM's latest predictions, medical device labs-on-a-chip will serve as health detectives for tracing disease at the nanoscale. In the next five years, new medical device labs-on-a-chip will serve as nanotechnology health detectives – tracing...

Type 2 diabetes has escalated to epidemic and financially catastrophic proportions, and is expected to affect one in three US adults by 2050. We already have more than 29 million diabetics in this country today; 28% remain undiagnosed. With the well-established...

Dental patients with severe periodontitis may have undiagnosed type 2 diabetes, Dutch researchers have discovered in a study that suggests targeted screening of individuals with worse gum disease could be a feasible way of picking up cases of diabetes at...

…. Clara Camaschella, MD, Deputy Director Division of Genetics and Cell Biology, Head of the Unit “Regulation of iron metabolism”, Professor of Internal Medicine, University hospital San Raffaele Milan, Italy; Anders Larsson, MD, PhD, Professor, Section of...

dianax is pleased to announce the first members of its newly formed Clinical Advisory Board ("CAB"). The CAB, comprising key thought leaders in point of need testing and subject matter experts in diabetes and iron metabolism therapy management will provide...

HbA1c may be the most effective method to identify patients with undiagnosed prediabetes and diabetes, and point-of-care testing further enhances that screening ability in primary-care settings, new research suggests. The findings were published...

Eugenio Iannone, Dianax Founder and seminal book author of Labs on Chip: Principles, Design & Technology explains: “Miniaturization is one of the key technology that have changed the human life in the last decades, allowing to pack a huge number of...

One step closer to industrialization … dianax announces successful transfer of its BioMEMS chip technology to Silex Microsystems which will industrialize the present prototype and can produce the chip up to a volume of several million pieces a year. Silex...

dianax has been nominated the # 1 Start-up at BigBooster International Start-Up Acceleration Program in Lyon this week. (www.bigbooster.org ). Out of the 250 startups participating from Europe, Middle East and Africa, dianax ranked among the best 44 back...

The Italian financial journal Il Sole 24 Ore on its Magazine Platinum – Aziende & Protagonisti (Platinum – Companies and Business Leaders, in its English version) has published today a one-page article on Dianax in the issue of March 2018 under the...

According to a new market research report from MarketsandMarkets, the global home healthcare market is expected to reach USD 365 Billion by 2022 growing at a CAGR of 8.8 from 2017 to 2012. Testing, screening, and monitoring devices are expected to dominate...

At the end of a 3-day intensive program combining tutorial on best practices, mentoring and individual coaching, dianax ‘s pitch was recognized by an expert jury among the best in class and is qualified for the next round that will take the top 20 startups...

dianax miniaturized microfluidics-based lab-on-a-chip will bring laboratory testing to the patient’s fingertips including HbA1c and CRP. According to Data Bridge Market Research, the Europe Point-of-Care Testing (POCT) devices market is expected to reach...

Organized across the globe, from Lyon (FR) to Boston (MA, USA), passing through China, Middle East & Africa, BigBooster unique international non-profit acceleration program aims at empowering startups to cross borders, think global and go...

dianax is among the top 10 Alpine region startup companies qualified for the 2017 final of the Tech Tour European Venture Contest (EVC). A total of 105 companies applied to the event, only 40 of them were invited to pitch in front of international...

Dianax is among the top 40 Alpine region companies selected to present at the Forum on 10 October in Lausanne. 104 companies applied and were reviewed by the Expert Jury over the past months. At the Alpine Venture Forum 2016 took part +50 Swiss and...

According to a very recent report from Reports Monitor (ReportsMonitor.com), Point of care (POC) technologies are rapidly becoming parts of the revolution of the healthcare landscape, with evolving high–tech innovations in healthcare, including smartphone...

C-reactive protein (CRP) point of care tests may help reduce unnecessary antibiotic use. Sinus infections are one of the most common reasons patients walk out of the doctor’s office with an antibiotic prescription in hand. The problem is that bacteria...

According to IBM's latest predictions, medical device labs-on-a-chip will serve as health detectives for tracing disease at the nanoscale. In the next five years, new medical device labs-on-a-chip will serve as nanotechnology health detectives – tracing...

Type 2 diabetes has escalated to epidemic and financially catastrophic proportions, and is expected to affect one in three US adults by 2050. We already have more than 29 million diabetics in this country today; 28% remain undiagnosed. With the well-established...

Dental patients with severe periodontitis may have undiagnosed type 2 diabetes, Dutch researchers have discovered in a study that suggests targeted screening of individuals with worse gum disease could be a feasible way of picking up cases of diabetes at...

…. Clara Camaschella, MD, Deputy Director Division of Genetics and Cell Biology, Head of the Unit “Regulation of iron metabolism”, Professor of Internal Medicine, University hospital San Raffaele Milan, Italy; Anders Larsson, MD, PhD, Professor, Section of...

dianax is pleased to announce the first members of its newly formed Clinical Advisory Board ("CAB"). The CAB, comprising key thought leaders in point of need testing and subject matter experts in diabetes and iron metabolism therapy management will provide...

HbA1c may be the most effective method to identify patients with undiagnosed prediabetes and diabetes, and point-of-care testing further enhances that screening ability in primary-care settings, new research suggests. The findings were published...

Eugenio Iannone, Dianax Founder and seminal book author of Labs on Chip: Principles, Design & Technology explains: “Miniaturization is one of the key technology that have changed the human life in the last decades, allowing to pack a huge number of...

One step closer to industrialization … dianax announces successful transfer of its BioMEMS chip technology to Silex Microsystems which will industrialize the present prototype and can produce the chip up to a volume of several million pieces a year. Silex...